Evolution Wealth Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Evolution Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$16.79 - $27.09 $2,719 - $4,388	-162 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$15.78 - $24.77 $3,156 - $4,954	-200 Reduced 55.25%	162 $3,000
Q2 2021 Jul 22, 2021	SELL	$19.4 - $27.42 $4,190 - $5,922	-216 Reduced 37.37%	362 $9,000
Q1 2021 Apr 20, 2021	BUY	$25.02 - $54.99 $1,876 - $4,124	75 Added 14.91%	578 $15,000
Q4 2020 Feb 02, 2021	SELL	$41.04 - $56.79 $6,238 - $8,632	-152 Reduced 23.21%	503 $27,000
Q3 2020 Oct 15, 2020	BUY	$36.42 - $57.0 $9,105 - $14,250	250 Added 61.73%	655 $27,000
Q2 2020 Jul 27, 2020	BUY	$39.26 - $52.73 $15,900 - $21,355	405 New	405 $20,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.